venBio Select Advisor »

Tourmaline Bio shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2023-12-31 $23M 868k 26.18

More positions owned by venBio Select Advisor

Apellis Pharmaceuticals Common (APLS)
United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Argenx Se Sponsored ADR (ARGX)
Madrigal Pharmaceuticals Common (MDGL)
Sarepta Therapeutics Common (SRPT)
Biomarin Pharmaceutical Common (BMRN)
Spdr Series Trust - S&p Biotech Etf (XBI)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Krystal Biotech Common (KRYS)
Mirati Therapeutics Common
Cymabay Therapeutics Common
Xenon Pharmaceuticals Common (XENE)
Alnylam Pharmaceuticals Common (ALNY)

View all positions for venBio Select Advisor

Top funds holding Tourmaline Bio

Blue Owl Capital Holdings
QVT Financial
Braidwell
venBio Select Advisor
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Qiming U.S. Ventures Management
Vivo Capital
Nantahala Capital Management
Balyasny Asset Management
Logos Global Management
Artal Group
AlphaCentric Advisors
Two Sigma Investments
HighTower Advisors

View all funds holding Tourmaline Bio